Atossa Therapeutics
ATOS
ATOS
86 hedge funds and large institutions have $41.6M invested in Atossa Therapeutics in 2024 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 21 increasing their positions, 24 reducing their positions, and 6 closing their positions.
Holders
86
Holders Change
+9
Holders Change %
+11.69%
% of All Funds
1.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
21
Reduced
24
Closed
6
Calls
$1M
Puts
$169K
Net Calls
+$835K
Net Calls Change
+$173K
Top Buyers
| 1 |
1
Northern Trust
Chicago,
Illinois
|
$1.45M |
| 2 |
2
BlackRock
New York
|
$14.7M |
| 3 |
3
Goldman Sachs
New York
|
$379K |
| 4 |
4
Barclays
London,
United Kingdom
|
$255K |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$10M |
Top Sellers
| 1 |
1
Renaissance Technologies
New York
|
$1.99M |
| 2 |
2
Jane Street
New York
|
$208K |
| 3 |
3
Bank of New York Mellon
New York
|
$462K |
| 4 |
4
Two Sigma Investments
New York
|
$146K |
| 5 |
5
Mariner
Overland Park,
Kansas
|
$0 |
